Clinical trials: Muscle Relaxant
- Condition Muscle Relaxant
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Target Drug-related Adverse Events
Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens
The purpose of this study is to determine whether the addition of selective pharmacogenomic (PGx) testing as determined by Urine Drug Testing (UDT) adds a clinical benefit as evidenced by a reduction in Target Drug-related…
- Trial name
- SPHERE (NCT02625155)
- Testing
- Urine diagnostic testing as SOC, drug regimen changes per SOC, Urine diagnostic testing with selective PGx testing, drug regimen changes based on PGx test results
- Where
- United States
- Volunteers
- 14,000 people, healthy volunteers welcome
- Sponsor
- InSource Diagnostics
Flaccidity, Muscle
Efficacy and Safety of Poly-L-lactic Acid
This study aims to assess efficacy and safety of Sculptra in the treatment of skin flaccidity in selected areas - arms, anteromedial region, and gluteal regions.
- Trial name
- Sculptra (NCT03225066)
- Testing
- Poly-L-lactic acid - Sculptra
- Where
- 4 sites in Brazil
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Galderma Brasil Ltda.